换一批
换一批Evolution of sequential bortezomib-dexamethasone treatment followed by autologous hematopoietic stem cell transplantation in hemodialysis treatment
摘要To the editor:We read with interest the article of Zheng et al1 on sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation (ASCT) in patients with multiple myeloma (MM).Nephrologists are interested in the treatment of acute renal failure (ARF) in the course of MM because the survival of patients is affected by the recovery of normal renal function,not only for the specific complications of ARF but also for the reduced opportunities for access to more effective drug treatments.To date,the evolution of renal disorders associated with monoclonal light chains in MM remain poorly defined.
更多相关知识
栏目名称
LETTERS
DOI
10.3760/cma.j.issn.0366-6999.20130532
发布时间
2013-08-05
- 浏览378
- 被引0
- 下载8
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
